NFG
HRTX icon

Next Financial Group’s Heron Therapeutics HRTX Stock Holding History

Next Financial Group’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-200
Closed -$3K – 2047
2016
Q4 		$3K Buy
+200
New +$3.14K ﹤0.01% 2077
2015
Q4 		– Sell
-2
Closed – – 1847
2015
Q3 		$0 Hold
2
– – ﹤0.01% 1876
2015
Q2 		$0 Hold
2
– – ﹤0.01% 1886
2015
Q1 		$0 Hold
2
– – ﹤0.01% 1890
2014
Q4 		$0 Hold
2
– – ﹤0.01% 2094
2014
Q3 		$0 Hold
2
– – ﹤0.01% 2533
2014
Q2 		$0 Buy
+2
New +$24 ﹤0.01% 1220

Other funds holding HRTX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Next Financial Group's HRTX Position: Q1 2017 in Review

Next Financial Group sold out of Heron Therapeutics (HRTX) in Q1 2017, closing a stake of 200 shares — an estimated $3K sold.

Next Financial Group first reported a position in HRTX in Q2 2014 and held it in 7 quarters. The position peaked at $3K in Q4 2016. 100 funds tracked by Wall St. Rank hold HRTX as of Q1 2017.

  • Next Financial Group reported no remaining Heron Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Next Financial Group sold 200 Heron Therapeutics shares in Q1 2017, an estimated $3K.
  • Next Financial Group first reported a position in Heron Therapeutics in Q2 2014 and held it in 7 quarters.
  • Next Financial Group's Heron Therapeutics position peaked at $3K in Q4 2016.
  • 100 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2017.

Based on Next Financial Group's 13F filing for Q1 2017, filed 8 May 2017.